Advertisement
Advertisement
U.S. markets open in 4 hours 35 minutes
Advertisement
Advertisement
Advertisement
Advertisement

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.7500-0.0500 (-6.25%)
At close: 04:00PM EDT
0.7770 +0.03 (+3.60%)
After hours: 05:30PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/21/2023
Current
6/30/20233/31/202312/31/20229/30/20226/30/2022
Market Cap (intraday)
12.26M12.20M7.19M18.53M30.96M35.99M
Enterprise Value
1.95M2.22M1.84M15.39M22.42M13.26M
Trailing P/E
0.190.170.120.360.72N/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
3.415.212.7510.589.8111.37
Price/Book (mrq)
1.180.860.330.680.93N/A
Enterprise Value/Revenue
0.968.77N/A61.0744.2223.26
Enterprise Value/EBITDA
-0.08-0.574.14-2.11-3.700.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.23
52-Week Change 3-83.70%
S&P500 52-Week Change 317.14%
52 Week High 34.8000
52 Week Low 30.5500
50-Day Moving Average 30.9730
200-Day Moving Average 31.2571

Share Statistics

Avg Vol (3 month) 3236.51k
Avg Vol (10 day) 3311.08k
Shares Outstanding 516.34M
Implied Shares Outstanding 616.34M
Float 812.59M
% Held by Insiders 10.93%
% Held by Institutions 110.10%
Shares Short (Aug 30, 2023) 4635.33k
Short Ratio (Aug 30, 2023) 41.74
Short % of Float (Aug 30, 2023) 44.91%
Short % of Shares Outstanding (Aug 30, 2023) 43.89%
Shares Short (prior month Jul 30, 2023) 41.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Oct 25, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-7,770.36%

Management Effectiveness

Return on Assets (ttm)-33.27%
Return on Equity (ttm)-68.59%

Income Statement

Revenue (ttm)253k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-55.60%
Gross Profit (ttm)-3.34M
EBITDA -18M
Net Income Avi to Common (ttm)-13.75M
Diluted EPS (ttm)-3.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.41M
Total Cash Per Share (mrq)0.45
Total Debt (mrq)N/A
Total Debt/Equity (mrq)23.66%
Current Ratio (mrq)2.09
Book Value Per Share (mrq)0.95

Cash Flow Statement

Operating Cash Flow (ttm)-21.23M
Levered Free Cash Flow (ttm)-3.78M
Advertisement
Advertisement